Holly Kramer
Pediatric Endocrinology · Des Moines, IANPI 1275836751
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations.
Across 155 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$771
- Insulet Corporation$374
- Novo Nordisk$338
- Kyowa Kirin, Inc.$238
- Eton Pharmaceuticals, Inc.$230
- Biomarin Pharmaceutical Inc.$201
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,703100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $771 |
| Insulet Corporation | 8 | $374 |
| Novo Nordisk | 16 | $338 |
| Kyowa Kirin, Inc. | 8 | $238 |
| Eton Pharmaceuticals, Inc. | 3 | $230 |
| Biomarin Pharmaceutical Inc. | 5 | $201 |
| Medtronic | 4 | $196 |
| Ascendis Pharma Endocrinology Inc | 11 | $193 |
| AstraZeneca | 8 | $184 |
| Sanofi-aventis U.S. LLC | 7 | $122 |
| Tolmar, Inc. | 5 | $114 |
| Tandem Diabetes Care, Inc. | 7 | $110 |
| Xeris Pharmaceuticals, Inc. | 5 | $102 |
| Pfizer | 6 | $97 |
| Abbott | 4 | $96 |
| Neurocrine Biosciences, Inc. | 4 | $79 |
| Azurity Pharmaceuticals, Inc. | 3 | $55 |
| Dexcom, Inc. | 3 | $55 |
| Endo USA, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Rhythm Pharmaceuticals, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$275
- Alkindi$179
- Lupron Depot$125
- CRYSVITA$121
- MINIMED 780G$111
- VOXZOGO 1.2mg$102
How this compares
Too few pediatric endocrinology providers in Iowato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Des Moines
- Courtney ReintsDes Moines$174K
- Erin RichardsonDes Moines$3K
- Teresa Monsod BorromeoDes Moines$2K
- Maria Parra VillasmilDes Moines$1K
- Jennifer CookDes Moines$231
- Akhila RamakrishnaIowa City$1K
- Michael TanseyIowa City$1K
- Eva TsalikianIowa City$230
- Eirene AlexandrouIowa City$200
- Lauren KannerIowa City$187
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.